Home › Funds › MBB PUBLIC MARKETS I LLC › KYTX
MBB PUBLIC MARKETS I LLC position in KYTX
KYVERNA THERAPEUTICS INC · Health Care
MBB PUBLIC MARKETS I LLC reported holding 614,477 shares of KYTX (KYVERNA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$4.2M, representing 0.50% of its reported portfolio and ranking #8 among its reported holdings. MBB PUBLIC MARKETS I LLC has disclosed KYTX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How MBB PUBLIC MARKETS I LLC's KYTX position evolved
MBB PUBLIC MARKETS I LLC first disclosed a stake in KYTX in Q2 2024 at 410,191 shares (US$3.1M). The position peaked in Q4 2025 at 614,477 shares, worth US$5.8M. Across 10 filings, MBB PUBLIC MARKETS I LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 614,477 shares valued at US$4.2M. Notable position changes include a 50% increase in Q3 2024 (shares fell 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 410.19K | $3.08M | New |
| Q3 2024 | 614.48K | $3.00M | Add |
| Q4 2024 | 614.48K | $2.30M | Hold |
| Q1 2025 | 614.48K | $1.19M | Hold |
| Q2 2025 | 614.48K | $1.89M | Hold |
| Q3 2025 | 614.48K | $3.69M | Hold |
| Q4 2025 | 614.48K | $5.78M | Hold |
| Q1 2026 | 614.48K | $5.30M | Hold |
| Q2 2026 | 614.48K | $5.47M | Hold |
| Q3 2026 | 614.48K | $4.18M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About KYTX and 13F data
KYTX (KYVERNA THERAPEUTICS INC) is a Health Care company. 36 other funds we track also report a position in KYTX — the largest reported positions include GordonMD Global Investments LP (US$30.7M), GILEAD SCIENCES, INC. (US$28.1M), AIGH Capital Management LLC (US$24.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding KYTX
- GordonMD Global Investments LP 4.52M sh · $30.74M · Q3 2026
- GILEAD SCIENCES, INC. 4.13M sh · $28.06M · Q3 2026
- AIGH Capital Management LLC 3.65M sh · $24.82M · Q3 2026
- Bain Capital Life Sciences Investors, LLC 1.31M sh · $8.92M · Q3 2026
- Insight Holdings Group, LLC 989.05K sh · $6.73M · Q3 2026
- Propel Bio Management, LLC 700.60K sh · $4.76M · Q3 2026
More on MBB PUBLIC MARKETS I LLC
FAQ
How long has MBB PUBLIC MARKETS I LLC held KYTX?
MBB PUBLIC MARKETS I LLC has disclosed KYTX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is MBB PUBLIC MARKETS I LLC's current position in KYTX?
As of Q3 2026, MBB PUBLIC MARKETS I LLC holds 614.48K shares of KYTX (KYVERNA THERAPEUTICS INC), valued at $4.18M, representing 0.50% of its reported portfolio and ranking #8.
Has MBB PUBLIC MARKETS I LLC been buying or selling KYTX?
In the latest 13F filing (Q3 2026), MBB PUBLIC MARKETS I LLC held unchanged its position in KYTX. The position peaked in Q4 2025 at 614.48K shares.
Which other funds hold KYTX?
Other major institutional holders of KYTX include GordonMD Global Investments LP, GILEAD SCIENCES, INC., AIGH Capital Management LLC, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.